![](/img/cover-not-exists.png)
A phase 1 ascending dose study of a subcutaneously administered factor IXa inhibitor and its active control agent
J. P. VAVALLE, C. P. RUSCONI, S. ZELENKOFSKE, W. A. WARGIN, J. H. ALEXANDER, R. C. BECKERVolume:
10
Year:
2012
Language:
english
Pages:
1
DOI:
10.1111/j.1538-7836.2012.04742.x
File:
PDF, 430 KB
english, 2012